Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Theme
Innovative Discoveries and Challenges in Pharmaceutics
- Pharmaceutics 2019

Welcome Message


Dear Colleagues and Friends,

It is our great pleasure to announce and invite you to the second edition of, the 2nd International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems, which will be held from February 18-20, 2019 in Paris, France.

Pharmaceutics is an ever-evolving field of Pharmaceutical Sciences and Medicine. New solutions keep coming out all the time and you have to stay with the speed of the field. It is through gatherings like this one that you - Pharmacists - can keep pace with the latest happenings in the world of Pharmacology and Medicine.

To do so, we need to work together, learn from each other, and think of better solutions and approaches aimed at advancing and developing the future of Pharmacology.

For that, some of the best regional and international minds and faculty experts in the pharmacology and medicine will be our guests to enrich our programme.

The scientific conference of Pharmaceutics and Novel Drug Delivery Systems promises 3 days full of expertly curated content, thoughtful dialogue, skills development, keynote presentations, and fun from start to finish.

Pharmaceutics Exhibition will offer exhibitors and buyers and medical end users unparalleled opportunities to discover new products and devices, network with industry leaders, exchange experiences, and forge collaborative partnerships.

We are working hard to set-up Pharmaceutics Conference & Exhibition as a learning and business platform where regional and international expertise will meet to address scientific developments and new technologies in both pharmaceutical sciences and pharma industry.

We look forward to meeting you in Paris, in February 2019.

With Kind Regards
Pharmaceutics 2019 | Organising Committee Members

Session & Tracks

Session on Innovations in Drug Discovery & Drug Development

Related:  Pharmaceutics Conferences | Pharmaceutics Events | Drug Delivery ConferencesPharma ConferencesPharmaceutics Conferences | Drug Discovery Conferences | Pharmaceutics Congress

It is the process to discover a new drug and bringing a drug to the market once a lead compound has been identified through the process of drug discoveryDrug Discovery & Development is these days a cloud-based, intellectual solution which analyses scientific knowledge and data to unveil known, unknown & hidden connectivity that can help increase the vast possibilities of scientific development. It is used by pharmaceutics companies, medical device companies and academic institutions to assist with new drug target identification and drug re-purposing.

Related Conferences: 18th World Conference on Basic and Clinical Pharmaceutics |July 1-6,2018 Kyoto, Japan; 20th International Pharmaceutics Conference on Drug Interactions and Reactions | July 12-13, 2018 Stockholm, Sweden; Drug Development & Scale-Up in the Fine Chemical & Pharmaceutics Industries | Jun 19-21, 2018 Vienna, Austria ; 20th International Conference on Drug Development Technologies and Clinical Drug Design | July 9-10, 2018 Prague, Czech Republic; EILAT XIV - Fourteenth EILAT Pharmaceutics Conference on New Antiepileptic Drugs and Devices | May 13-16, 2018 Madrid, Spain;  ICDCI 2018: 20th International Pharmaceutics Conference on Drug-Condition Interactions | September 21 - 22, 2018 Amsterdam, Netherlands; 

Related Associations: European Association for Clinical PharmaceuticsEuropean Behavioural Pharmaceutics Society (EBPS), European Federation for Pharmaceutics Sciences (EUFEPS), Italian Society for Pharmaceutics Sciences (SISF), Belgian Society of Pharmaceutics SciencesSpanish Society of Pharmaceutics and Pharmaceutics Technology (SEFC)

Session on Analytical Methods and Control Strategies

Related:  Pharmaceutics Conferences | Pharmaceutics Events | Drug Delivery ConferencesPharma ConferencesPharmaceutics Conferences | Drug Discovery Conferences | Pharmaceutics Congress

There is a noted interest in exaggerating the approaches for analytical method development drug validation. for drug development, the main key is Quality by Design. The enhanced approaches mostly utilize risk assessments and in-depth systematic evaluations of critical Pharmaceutics Analysis & Quality Control will enable you to expertise in the quality assurance and quality control of products. The session has a strong scientific approach, and we have specifically designed it to improve the skills of pharmacists.

Related Conferences: 18th World Conference on Basic and Clinical Pharmaceutics |July 1-6,2018 Kyoto, Japan; 20th International Pharmaceutics Conference on Drug Interactions and Reactions | July 12-13, 2018 Stockholm, Sweden; Drug Development & Scale-Up in the Fine Chemical & Pharmaceutics Industries | Jun 19-21, 2018 Vienna, Austria ; 20th International Conference on Drug Development Technologies and Clinical Drug Design | July 9-10, 2018 Prague, Czech Republic; EILAT XIV - Fourteenth EILAT Pharmaceutics Conference on New Antiepileptic Drugs and Devices | May 13-16, 2018 Madrid, Spain;  ICDCI 2018: 20th International Pharmaceutics Conference on Drug-Condition Interactions | September 21 - 22, 2018 Amsterdam, Netherlands; 

Related Associations: European Association for Clinical PharmaceuticsEuropean Behavioural Pharmaceutics Society (EBPS), European Federation for Pharmaceutics Sciences (EUFEPS), Italian Society for Pharmaceutics Sciences (SISF), Belgian Society of Pharmaceutics SciencesSpanish Society of Pharmaceutics and Pharmaceutics Technology (SEFC)

Session on  Pharmaceutics Sciences

Related:  Pharmaceutics Conferences | Pharmaceutics Events | Drug Delivery ConferencesPharma ConferencesPharmaceutics Conferences | Drug Discovery Conferences | Pharmaceutics Congress

The pharmaceutics sciences together form a wide range of scientific branches that are involved in the discovery and development of new drugs and therapies. Pharmaceutics sciences are broadly categorized, with many specialized fields within each category. The pharmaceutics sciences are a group of interdisciplinary areas of study concerned with the design, action, delivery and disposition of drugs.

Related Conferences: 18th World Conference on Basic and Clinical Pharmaceutics |July 1-6,2018 Kyoto, Japan; 20th International Pharmaceutics Conference on Drug Interactions and Reactions | July 12-13, 2018 Stockholm, Sweden; Drug Development & Scale-Up in the Fine Chemical & Pharmaceutics Industries | Jun 19-21, 2018 Vienna, Austria ; 20th International Conference on Drug Development Technologies and Clinical Drug Design | July 9-10, 2018 Prague, Czech Republic; EILAT XIV - Fourteenth EILAT Pharmaceutics Conference on New Antiepileptic Drugs and Devices | May 13-16, 2018 Madrid, Spain;  ICDCI 2018: 20th International Pharmaceutics Conference on Drug-Condition Interactions | September 21 - 22, 2018 Amsterdam, Netherlands; 

Related Associations: European Association for Clinical PharmaceuticsEuropean Behavioural Pharmaceutics Society (EBPS), European Federation for Pharmaceutics Sciences (EUFEPS), Italian Society for Pharmaceutics Sciences (SISF), Belgian Society of Pharmaceutics SciencesSpanish Society of Pharmaceutics and Pharmaceutics Technology (SEFC)

Session on  Pharmaceutics Engineering

Related:  Pharmaceutics Conferences | Pharmaceutics Events | Drug Delivery ConferencesPharma ConferencesPharmaceutics Conferences | Drug Discovery Conferences | Pharmaceutics Congress

Pharmaceutics engineering is a branch of pharmaceutics science and technology that involves the development and manufacturing of products, processes, and components in the pharmaceutics industry. While developing pharmaceutics products involves many interrelated disciplines like medicinal chemists, analytical chemists, clinicians/pharmacologistspharmacists, chemical engineers, biomedical engineers, etc, the specific sub-field of "pharmaceutics engineering" has only emerged recently as a distinct engineering discipline. This now brings the problem-solving principles and quantitative training of engineering to complement the other scientific fields already involved in drug development.

Pharmaceutics engineering is a branch of pharmaceutics science and technology that involves the development and manufacturing of products, processes, and components in the pharmaceutics industry.

Related Conferences: 18th World Conference on Basic and Clinical Pharmaceutics |July 1-6,2018 Kyoto, Japan; 20th International Pharmaceutics Conference on Drug Interactions and Reactions | July 12-13, 2018 Stockholm, Sweden; Drug Development & Scale-Up in the Fine Chemical & Pharmaceutics Industries | Jun 19-21, 2018 Vienna, Austria ; 20th International Conference on Drug Development Technologies and Clinical Drug Design | July 9-10, 2018 Prague, Czech Republic; EILAT XIV - Fourteenth EILAT Pharmaceutics Conference on New Antiepileptic Drugs and Devices | May 13-16, 2018 Madrid, Spain;  ICDCI 2018: 20th International Pharmaceutics Conference on Drug-Condition Interactions | September 21 - 22, 2018 Amsterdam, Netherlands; 

Related Associations: European Association for Clinical PharmaceuticsEuropean Behavioural Pharmaceutics Society (EBPS), European Federation for Pharmaceutics Sciences (EUFEPS), Italian Society for Pharmaceutics Sciences (SISF), Belgian Society of Pharmaceutics SciencesSpanish Society of Pharmaceutics and Pharmaceutics Technology (SEFC)

Session on  Clinical Trials

Related:  Pharmaceutics Conferences | Pharmaceutics Events | Drug Delivery ConferencesPharma ConferencesPharmaceutics Conferences | Drug Discovery Conferences | Pharmaceutics Congress

Clinical trials are experiments and the outcomes that is done during a clinical researchClinical trials promise data on safety and expected result. They are conducted only after they have received authority committee approval in the country where approval of the same is solicited. These authority’s approval does not mean that the therapy is 'safe' or effective, only that the trial is conducted, and the result is unknown in the initial stage.

Related Conferences: 18th World Conference on Basic and Clinical Pharmaceutics |July 1-6,2018 Kyoto, Japan; 20th International Pharmaceutics Conference on Drug Interactions and Reactions | July 12-13, 2018 Stockholm, Sweden; Drug Development & Scale-Up in the Fine Chemical & Pharmaceutics Industries | Jun 19-21, 2018 Vienna, Austria ; 20th International Conference on Drug Development Technologies and Clinical Drug Design | July 9-10, 2018 Prague, Czech Republic; EILAT XIV - Fourteenth EILAT Pharmaceutics Conference on New Antiepileptic Drugs and Devices | May 13-16, 2018 Madrid, Spain;  ICDCI 2018: 20th International Pharmaceutics Conference on Drug-Condition Interactions | September 21 - 22, 2018 Amsterdam, Netherlands; 

Related Associations: European Association for Clinical PharmaceuticsEuropean Behavioural Pharmaceutics Society (EBPS), European Federation for Pharmaceutics Sciences (EUFEPS), Italian Society for Pharmaceutics Sciences (SISF), Belgian Society of Pharmaceutics SciencesSpanish Society of Pharmaceutics and Pharmaceutics Technology (SEFC)

Session on  Clinical Pharmacy

Related:  Pharmaceutics Conferences | Pharmaceutics Events | Drug Delivery ConferencesPharma ConferencesPharmaceutics Conferences | Drug Discovery Conferences | Pharmaceutics Congress

Clinical pharmacy is the branch of pharmacy in which pharmacists provide patient care that optimizes the use of medication and promotes health, wellness, and disease prevention. Clinical pharmacists care for patients in all healthcare settings but the clinical pharmacy movement initially began inside hospitals and clinics. Clinical pharmacists often work in collaboration with physicians, nurse practitioners, and other healthcare professionals.

Related Conferences: 18th World Conference on Basic and Clinical Pharmaceutics |July 1-6,2018 Kyoto, Japan; 20th International Pharmaceutics Conference on Drug Interactions and Reactions | July 12-13, 2018 Stockholm, Sweden; Drug Development & Scale-Up in the Fine Chemical & Pharmaceutics Industries | Jun 19-21, 2018 Vienna, Austria ; 20th International Conference on Drug Development Technologies and Clinical Drug Design | July 9-10, 2018 Prague, Czech Republic; EILAT XIV - Fourteenth EILAT Pharmaceutics Conference on New Antiepileptic Drugs and Devices | May 13-16, 2018 Madrid, Spain;  ICDCI 2018: 20th International Pharmaceutics Conference on Drug-Condition Interactions | September 21 - 22, 2018 Amsterdam, Netherlands; 

Related Associations: European Association for Clinical PharmaceuticsEuropean Behavioural Pharmaceutics Society (EBPS), European Federation for Pharmaceutics Sciences (EUFEPS), Italian Society for Pharmaceutics Sciences (SISF), Belgian Society of Pharmaceutics SciencesSpanish Society of Pharmaceutics and Pharmaceutics Technology (SEFC)

Session on  Nanotechnology in Drug Delivery

Related:  Pharmaceutics Conferences | Pharmaceutics Events | Drug Delivery ConferencesPharma ConferencesPharmaceutics Conferences | Drug Discovery Conferences | Pharmaceutics Congress

In drug deliverynanotechnology plays the important role where the study of extremely small things and its application can be used across all the other science fields. By using this technology, the particles in the drug which are engineered in such a way that they can attract to the diseased cell and allows treatment to the cell directly. Through this unique technique, we can minimize the damage of healthy cells in the body.

Related Conferences: 18th World Conference on Basic and Clinical Pharmaceutics |July 1-6,2018 Kyoto, Japan; 20th International Pharmaceutics Conference on Drug Interactions and Reactions | July 12-13, 2018 Stockholm, Sweden; Drug Development & Scale-Up in the Fine Chemical & Pharmaceutics Industries | Jun 19-21, 2018 Vienna, Austria ; 20th International Conference on Drug Development Technologies and Clinical Drug Design | July 9-10, 2018 Prague, Czech Republic; EILAT XIV - Fourteenth EILAT Pharmaceutics Conference on New Antiepileptic Drugs and Devices | May 13-16, 2018 Madrid, Spain;  ICDCI 2018: 20th International Pharmaceutics Conference on Drug-Condition Interactions | September 21 - 22, 2018 Amsterdam, Netherlands; 

Related Associations: European Association for Clinical PharmaceuticsEuropean Behavioural Pharmaceutics Society (EBPS), European Federation for Pharmaceutics Sciences (EUFEPS), Italian Society for Pharmaceutics Sciences (SISF), Belgian Society of Pharmaceutics SciencesSpanish Society of Pharmaceutics and Pharmaceutics Technology (SEFC)

Session on  Pharmacotherapeutics

Related:  Pharmaceutics Conferences | Pharmaceutics Events | Drug Delivery ConferencesPharma ConferencesPharmaceutics Conferences | Drug Discovery Conferences | Pharmaceutics Congress

Pharmacotherapeutics the study of the therapeutic uses and effects of drugsPharmacists are professionals in pharmacotherapy and are key persons in guaranteeing the suitable, protected and proper use of pharmaceutics medications. Pharmacists have duty regarding direct patient care, regularly working as an individual from a multidisciplinary group. A pharmacotherapy expert is a person who is spending significant time in managing and endorsing medicine and requires broad knowledge in pharmacotherapy.

Related Conferences: 18th World Conference on Basic and Clinical Pharmaceutics |July 1-6,2018 Kyoto, Japan; 20th International Pharmaceutics Conference on Drug Interactions and Reactions | July 12-13, 2018 Stockholm, Sweden; Drug Development & Scale-Up in the Fine Chemical & Pharmaceutics Industries | Jun 19-21, 2018 Vienna, Austria ; 20th International Conference on Drug Development Technologies and Clinical Drug Design | July 9-10, 2018 Prague, Czech Republic; EILAT XIV - Fourteenth EILAT Pharmaceutics Conference on New Antiepileptic Drugs and Devices | May 13-16, 2018 Madrid, Spain;  ICDCI 2018: 20th International Pharmaceutics Conference on Drug-Condition Interactions | September 21 - 22, 2018 Amsterdam, Netherlands; 

Related Associations: European Association for Clinical PharmaceuticsEuropean Behavioural Pharmaceutics Society (EBPS), European Federation for Pharmaceutics Sciences (EUFEPS), Italian Society for Pharmaceutics Sciences (SISF), Belgian Society of Pharmaceutics SciencesSpanish Society of Pharmaceutics and Pharmaceutics Technology (SEFC)

Session on Pharmaceutics Care

Related:  Pharmaceutics Conferences | Pharmaceutics Events | Drug Delivery ConferencesPharma ConferencesPharmaceutics Conferences | Drug Discovery Conferences | Pharmaceutics Congress

Pharmaceutics Care is a patient-centered, outcomes oriented pharmaceutics practice that requires the pharmacist to work in concert with the patient the pharmaceutics care plan is a written, individualized, comprehensive medication therapy plan based on clearly defined therapeutic goals. Pharmaceutics care is a philosophy of practice in which the patient is the primary beneficiary of the pharmacist’s actions. Pharmaceutics care focuses the attitudes, behaviors, commitments, concerns, ethics, functions, knowledge, responsibilities and skills of the pharmacist on the provision of drug therapy with the goal of achieving definite therapeutic outcomes toward patient health and quality of life. The pharmaceutics care plan, which is available to all pharmacists caring for a patient, is updated with each major change in patient status and the patient's other healthcare providers to promote health, to prevent disease, and to assess, monitor, initiate, and modify medication use to assure that drug therapy regimens are safe and effective.

Related Conferences: 18th World Conference on Basic and Clinical Pharmaceutics |July 1-6,2018 Kyoto, Japan; 20th International Pharmaceutics Conference on Drug Interactions and Reactions | July 12-13, 2018 Stockholm, Sweden; Drug Development & Scale-Up in the Fine Chemical & Pharmaceutics Industries | Jun 19-21, 2018 Vienna, Austria ; 20th International Conference on Drug Development Technologies and Clinical Drug Design | July 9-10, 2018 Prague, Czech Republic; EILAT XIV - Fourteenth EILAT Pharmaceutics Conference on New Antiepileptic Drugs and Devices | May 13-16, 2018 Madrid, Spain;  ICDCI 2018: 20th International Pharmaceutics Conference on Drug-Condition Interactions | September 21 - 22, 2018 Amsterdam, Netherlands; 

Related Associations: European Association for Clinical PharmaceuticsEuropean Behavioural Pharmaceutics Society (EBPS), European Federation for Pharmaceutics Sciences (EUFEPS), Italian Society for Pharmaceutics Sciences (SISF), Belgian Society of Pharmaceutics SciencesSpanish Society of Pharmaceutics and Pharmaceutics Technology (SEFC)

Session on Safety Pharmacology

Related:  Pharmaceutics Conferences | Pharmaceutics Events | Drug Delivery ConferencesPharma ConferencesPharmaceutics Conferences | Drug Discovery Conferences | Pharmaceutics Congress

Safety pharmacology is an essential part of the drug formulation process that targets to identify and predict adverse effects prior to clinical trials. Supplemental safety pharmacology studies evaluate the effects of a new chemical entity at both anticipated therapeutic and supra-therapeutic exposures on major organ systems, including cardiovascular, central nervous, respiratory, renal and gastrointestinal. The newer approaches to routine safety pharmacology studies may diversely enhance the scope of safety pharmacology by refining and providing mechanistic insight to potential adverse effects associated with test compounds.

Related Conferences: 18th World Conference on Basic and Clinical Pharmaceutics |July 1-6,2018 Kyoto, Japan; 20th International Pharmaceutics Conference on Drug Interactions and Reactions | July 12-13, 2018 Stockholm, Sweden; Drug Development & Scale-Up in the Fine Chemical & Pharmaceutics Industries | Jun 19-21, 2018 Vienna, Austria ; 20th International Conference on Drug Development Technologies and Clinical Drug Design | July 9-10, 2018 Prague, Czech Republic; EILAT XIV - Fourteenth EILAT Pharmaceutics Conference on New Antiepileptic Drugs and Devices | May 13-16, 2018 Madrid, Spain;  ICDCI 2018: 20th International Pharmaceutics Conference on Drug-Condition Interactions | September 21 - 22, 2018 Amsterdam, Netherlands; 

Related Associations: European Association for Clinical PharmaceuticsEuropean Behavioural Pharmaceutics Society (EBPS), European Federation for Pharmaceutics Sciences (EUFEPS), Italian Society for Pharmaceutics Sciences (SISF), Belgian Society of Pharmaceutics SciencesSpanish Society of Pharmaceutics and Pharmaceutics Technology (SEFC)

Session on  Pharmacovigilance

Related:  Pharmaceutics Conferences | Pharmaceutics Events | Drug Delivery ConferencesPharma ConferencesPharmaceutics Conferences | Drug Discovery Conferences | Pharmaceutics Congress

Pharmacovigilance is defined as the science and activities relating to the detection, evaluation, understanding, and prevention of adverse drug reactions to medicines or any other medicine-related problems. The definition and scope of pharmacovigilance have evolved to recognize the importance of a systems approach for monitoring and improving the safe use of medicines.

Related Conferences: 18th World Conference on Basic and Clinical Pharmaceutics |July 1-6,2018 Kyoto, Japan; 20th International Pharmaceutics Conference on Drug Interactions and Reactions | July 12-13, 2018 Stockholm, Sweden; Drug Development & Scale-Up in the Fine Chemical & Pharmaceutics Industries | Jun 19-21, 2018 Vienna, Austria ; 20th International Conference on Drug Development Technologies and Clinical Drug Design | July 9-10, 2018 Prague, Czech Republic; EILAT XIV - Fourteenth EILAT Pharmaceutics Conference on New Antiepileptic Drugs and Devices | May 13-16, 2018 Madrid, Spain;  ICDCI 2018: 20th International Pharmaceutics Conference on Drug-Condition Interactions | September 21 - 22, 2018 Amsterdam, Netherlands; 

Related Associations: European Association for Clinical PharmaceuticsEuropean Behavioural Pharmaceutics Society (EBPS), European Federation for Pharmaceutics Sciences (EUFEPS), Italian Society for Pharmaceutics Sciences (SISF), Belgian Society of Pharmaceutics SciencesSpanish Society of Pharmaceutics and Pharmaceutics Technology (SEFC)

Session on  Risk Management and Analysis

Related:  Pharmaceutics Conferences | Pharmaceutics Events | Drug Delivery ConferencesPharma ConferencesPharmaceutics Conferences | Drug Discovery Conferences | Pharmaceutics Congress

Risk management and analysis is a set of interventions designed to identify, characterize, prevent or minimize risks relating to medicinal products. Pharmaceutics companies are attempting to address the challenges of on-market drug risk management within complicated and often highly charged business, social and political contexts. While drug manufacturers and healthcare providers must pledge to “first, do no harm,” today’s demanding patients seek perfect pills that can cure the most persistent diseases. The safety standards for pharmaceutics products are significantly higher than those imposed on nearly all other industries. As a result, even when the incidence of AEs is extremely low, drugs can still be withdrawn from the market. And, in our litigious society, if a drug is used widely, the scope alone makes it likely that litigation will ensue, even if only a small proportion of patients is affected.

Related Conferences: 18th World Conference on Basic and Clinical Pharmaceutics |July 1-6,2018 Kyoto, Japan; 20th International Pharmaceutics Conference on Drug Interactions and Reactions | July 12-13, 2018 Stockholm, Sweden; Drug Development & Scale-Up in the Fine Chemical & Pharmaceutics Industries | Jun 19-21, 2018 Vienna, Austria ; 20th International Conference on Drug Development Technologies and Clinical Drug Design | July 9-10, 2018 Prague, Czech Republic; EILAT XIV - Fourteenth EILAT Pharmaceutics Conference on New Antiepileptic Drugs and Devices | May 13-16, 2018 Madrid, Spain;  ICDCI 2018: 20th International Pharmaceutics Conference on Drug-Condition Interactions | September 21 - 22, 2018 Amsterdam, Netherlands; 

Related Associations: European Association for Clinical PharmaceuticsEuropean Behavioural Pharmaceutics Society (EBPS), European Federation for Pharmaceutics Sciences (EUFEPS), Italian Society for Pharmaceutics Sciences (SISF), Belgian Society of Pharmaceutics SciencesSpanish Society of Pharmaceutics and Pharmaceutics Technology (SEFC)

Session on  Drug Safety Testing

Related:  Pharmaceutics Conferences | Pharmaceutics Events | Drug Delivery ConferencesPharma ConferencesPharmaceutics Conferences | Drug Discovery Conferences | Pharmaceutics Congress

Drug safety remains a peak problem at a point when the cost and time required to develop a new drug are at an all-time high. Balancing the risk and the expected clinical benefit is the prime purpose of a preclinical and clinical testing. We offer an expanded perceptive on the application of predictive testing strategies and technologies to early safety decisions and suggest the narrow focus for improving preclinical safety testing to the problems that contribute most to adverse drug reactions.

Related Conferences: 18th World Conference on Basic and Clinical Pharmaceutics |July 1-6,2018 Kyoto, Japan; 20th International Pharmaceutics Conference on Drug Interactions and Reactions | July 12-13, 2018 Stockholm, Sweden; Drug Development & Scale-Up in the Fine Chemical & Pharmaceutics Industries | Jun 19-21, 2018 Vienna, Austria ; 20th International Conference on Drug Development Technologies and Clinical Drug Design | July 9-10, 2018 Prague, Czech Republic; EILAT XIV - Fourteenth EILAT Pharmaceutics Conference on New Antiepileptic Drugs and Devices | May 13-16, 2018 Madrid, Spain;  ICDCI 2018: 20th International Pharmaceutics Conference on Drug-Condition Interactions | September 21 - 22, 2018 Amsterdam, Netherlands; 

Related Associations: European Association for Clinical PharmaceuticsEuropean Behavioural Pharmaceutics Society (EBPS), European Federation for Pharmaceutics Sciences (EUFEPS), Italian Society for Pharmaceutics Sciences (SISF), Belgian Society of Pharmaceutics SciencesSpanish Society of Pharmaceutics and Pharmaceutics Technology (SEFC)

Session on  Industrial Pharmacy

Related:  Pharmaceutics Conferences | Pharmaceutics Events | Drug Delivery ConferencesPharma ConferencesPharmaceutics Conferences | Drug Discovery Conferences | Pharmaceutics Congress

Industrial Pharmacy involves manufacturing, developing, marketing and distributing of new drug product including quality assurance of these drugs. This broad research area relates to different functions in the pharmaceutics industry and having contact areas with engineering and economics. In pharmacy drug regulatory affairs have a great influence on the drug development process and the success of it. 

Related Conferences: 18th World Conference on Basic and Clinical Pharmaceutics |July 1-6,2018 Kyoto, Japan; 20th International Pharmaceutics Conference on Drug Interactions and Reactions | July 12-13, 2018 Stockholm, Sweden; Drug Development & Scale-Up in the Fine Chemical & Pharmaceutics Industries | Jun 19-21, 2018 Vienna, Austria ; 20th International Conference on Drug Development Technologies and Clinical Drug Design | July 9-10, 2018 Prague, Czech Republic; EILAT XIV - Fourteenth EILAT Pharmaceutics Conference on New Antiepileptic Drugs and Devices | May 13-16, 2018 Madrid, Spain;  ICDCI 2018: 20th International Pharmaceutics Conference on Drug-Condition Interactions | September 21 - 22, 2018 Amsterdam, Netherlands; 

Related Associations: European Association for Clinical PharmaceuticsEuropean Behavioural Pharmaceutics Society (EBPS), European Federation for Pharmaceutics Sciences (EUFEPS), Italian Society for Pharmaceutics Sciences (SISF), Belgian Society of Pharmaceutics SciencesSpanish Society of Pharmaceutics and Pharmaceutics Technology (SEFC)

Session on  Global Pharmaceutics Market

Related:  Pharmaceutics Conferences | Pharmaceutics Events | Drug Delivery ConferencesPharma ConferencesPharmaceutics Conferences | Drug Discovery Conferences | Pharmaceutics Congress

The drug discovery services market is expected to reach USD 14.40 Billion by 2022 from USD 8.32 Billion in 2017, at a CAGR of 11.6%. The major factors driving the growth of this market are highly dependent on its research and development segment. Few pharmaceutics companies invest 20 percent and more of their revenues in R&D sectors. Because of the steady loss of patent protection, the invention of new drugs is of vital importance for the pharmaceutics industry. Revenue losses due to patent expiry often are very significant, as can be seen with Pfizer’s Lipitor from 2012 on.

Related Conferences: 18th World Conference on Basic and Clinical Pharmaceutics |July 1-6,2018 Kyoto, Japan; 20th International Pharmaceutics Conference on Drug Interactions and Reactions | July 12-13, 2018 Stockholm, Sweden; Drug Development & Scale-Up in the Fine Chemical & Pharmaceutics Industries | Jun 19-21, 2018 Vienna, Austria ; 20th International Conference on Drug Development Technologies and Clinical Drug Design | July 9-10, 2018 Prague, Czech Republic; EILAT XIV - Fourteenth EILAT Pharmaceutics Conference on New Antiepileptic Drugs and Devices | May 13-16, 2018 Madrid, Spain;  ICDCI 2018: 20th International Pharmaceutics Conference on Drug-Condition Interactions | September 21 - 22, 2018 Amsterdam, Netherlands; 

Related Associations: European Association for Clinical PharmaceuticsEuropean Behavioural Pharmaceutics Society (EBPS), European Federation for Pharmaceutics Sciences (EUFEPS), Italian Society for Pharmaceutics Sciences (SISF), Belgian Society of Pharmaceutics SciencesSpanish Society of Pharmaceutics and Pharmaceutics Technology (SEFC)

Session on  Entrepreneurs Investment Get-together

Related:  Pharmaceutics Conferences | Pharmaceutics Events | Drug Delivery ConferencesPharma ConferencesPharmaceutics Conferences | Drug Discovery Conferences | Pharmaceutics Congress

Entrepreneurs play a key role in any economy. These people have the skills and initiative necessary to anticipate current and future needs and bring good new ideas to marketEntrepreneurs who prove to be successful in taking on the risks of a start-up are rewarded with profits, fame and continued growth opportunities. Pharmaceutics 2019 is a platform aimed to connect Entrepreneurs, Proposers and the Investors worldwide. It aims to create and facilitate the most optimized and viable meeting place for engaging people in global business discussions, evaluation and execution of promising business ideas. An investor could be able to find out the highest potential investment opportunities globally, which provide good return on investment. For entrepreneurs, this would be an ideal place to find out suitable investors and partners to start and/or expand their business. Thus, it is a perfect place to connect Entrepreneurs, Business Owners, Entrepreneurs from any field can exhibit their products and can give a presentation on their products which should be helpful in business development and marketing.

Related Conferences: 18th World Conference on Basic and Clinical Pharmaceutics |July 1-6,2018 Kyoto, Japan; 20th International Pharmaceutics Conference on Drug Interactions and Reactions | July 12-13, 2018 Stockholm, Sweden; Drug Development & Scale-Up in the Fine Chemical & Pharmaceutics Industries | Jun 19-21, 2018 Vienna, Austria ; 20th International Conference on Drug Development Technologies and Clinical Drug Design | July 9-10, 2018 Prague, Czech Republic; EILAT XIV - Fourteenth EILAT Pharmaceutics Conference on New Antiepileptic Drugs and Devices | May 13-16, 2018 Madrid, Spain;  ICDCI 2018: 20th International Pharmaceutics Conference on Drug-Condition Interactions | September 21 - 22, 2018 Amsterdam, Netherlands; 

Related Associations: European Association for Clinical PharmaceuticsEuropean Behavioural Pharmaceutics Society (EBPS), European Federation for Pharmaceutics Sciences (EUFEPS), Italian Society for Pharmaceutics Sciences (SISF), Belgian Society of Pharmaceutics SciencesSpanish Society of Pharmaceutics and Pharmaceutics Technology (SEFC)

Market Analysis

The global pharmaceutical market is projected to reach 10.27 billion USD by 2025. The market is expected to see a growth at 13.1% CAGR owing to increasing incidence of Adverse Drug Reaction. The key driver for the growth of the pharmaceutical market is ADR’s. In 2015, the U.S. FDA received almost 253,017 serious adverse events and 44,693 deaths associated with adverse drug reactions (ADRs). This shows the possible demand for instigating safety and pharma services.

The statistic shows the projected growth of the world pharmaceutical market by the regional group between 2018 and 2022. It is expected that the pharmaceutical market will have a compound annual growth rate of 6 to 9 percent in this period.

This statistic describes the projected global pharmaceutical market growth for the period 2016-2021, measured by the compound annual growth rate (CAGR) and sorted by regional submarkets. It is expected that North America will grow at a CAGR of 4.3 percent.

The global market for natural & plant-derived drugs was valued at $23.2 billion in 2013 and $24.4 billion in 2014. This total market is expected to reach $35.4 billion in 2020, with a Compound Annual Growth Rate (CAGR) of 6.6% from 2015 to 2020.

Pharmaceuticals represented a US$300 bn-a-year market globally as of 2015, the World Health Organization states. The global pharmaceutical market is expected to surpass US$400 bn by 2018. Worldwide prescription drug sales forecasted to grow at a robust 6.5% (CAGR) through 2022 to reach $1.06trn. 32% of the 2022 increase in sales to come from orphan drugs (+$95bn).

The global advanced drug delivery market should grow from roughly $178.8 billion in 2015 to nearly $227.3 billion by 2020, with a compound annual growth rate (CAGR) of 4.9%.

The North American market should grow from nearly $75.7 billion in 2015 to $93.4 billion by 2020, a CAGR of 4.3%.

The European market should grow from roughly $57.3 billion in 2015 to nearly $72.1 billion by 2020, a CAGR of 4.7%.

Although mature markets continue to account for over half of all global revenue of the pharmaceutical industry, both large and niche pharmaceutical companies are now waking up to the lucrative potential that lies in growth markets. Costs associated with bringing new molecules to the commercial space are progressively rising. To add to this, new medicines launches have continued to chart a flat graph. This could, however, also be an enormous opportunity for pharmaceutical companies in both mature and growth markets.

About Conference & Past Conference Report

Salient Features: 

Pharmaceutics 2019 emphasis on the Innovative Discoveries and Challenges in Pharmaceutics and update yourself to drive your market share accordingly. Learn about the applications of novel drug delivery systems for treating major diseases to progress the drug portfolio industrialization pathways.

Benefits of Attending:

· Networking Opportunities, Grow Your Professional Network

· Build Your Knowledge Base

· Expand Your Resources

· Meet Experts & Influencers Face to Face

· Learning in a New Space

· Break Out of Your Comfort Zone

· New Tips & Tactics

· Greater Focus

 

Reasons to Attend:

Dissect the challenges before looking for concrete solutions. Share experiences, insights, and ways in interactive peer-to-peer roundtables. Discover how scientific formulation advancements are being implemented in practice. Performances of intelligent drug delivery systems are endlessly improved with the aim to maximize therapeutic activity and to cut back undesirable side-effects.

This conference describes the innovative technologies in pharmaceutics and advances in drug delivery systems. Novel approaches regarding drug delivery systems development and industrializing insights & gain the most recent technologies regarding novel drug delivery systems and applications.


Target Audience:

  • Academicians and Professors     
  • Medical Colleges             
  • Scientists                                
  • Training Institutes           
  • Pharmacologists                     
  • Clinical Data Management
  • Business Entrepreneurs
  • Biomedical Companies
  • Biotechnology Companies
  • Medical Devices Manufacturing Companies


Past Conference Report :


We would like to thank all our wonderful keynotes, speakers, conference attendees, students, making Pharmaceutics 2018 a successful and splendid event.

Allied Academies Conferences hosted the event of International Conference & Exhibition on Pharmaceutics and Novel Drug Delivery Systems during June 21-23, 2018 at Renaissance London Heathrow Hotel with the theme “Novel Advances and Challenges in Pharmaceutics and Drug Delivery Systems”. Benevolent response and active participation were received from the Editorial Board Members of supporting International Journals as well as from the leading academic scientists, researchers, research scholars, students and leaders from the fields of Pharmaceutics who made this event successful.

The conference was marked by the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 5 countries, who have driven this event into the path of success. The conference highlighted through various sessions on current retroviral research.

Pharmaceutics 2018 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the fields of Pharmaceutics.

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

·         Drug delivery

·         Pharmaceutical Analysis and Quality Assurance

·         Drug discovery and Screening

·         Drug Toxicity

·         Adverse Drug Reaction

·         Pharmaceutical Nanotechnology

·         Industrial Pharmacy

 

The conference proceedings were carried out through various Scientific-sessions and plenary lectures. The conference was embarked with an opening ceremony followed by a series of lectures delivered by both Honourable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were:

  • Alexander M Seifalian | The London BioScience Innovation Centre | UK
  • Joshua Boateng | University of Greenwich| UK
  • Shraddha S Ghodke | UCL School of Pharmacy |UK
  • Xu Deng | University of Electronic Science and Technology of China| China
  • Raymond Compton Jagessar | University of Guyana | Guyana
  • Piotr Stupski | Haptic Systems | Poland
  • Ennio Capria | European Synchrotron Radiation Facility | France
  • Dimitris Drikakis | University of Strathclyde | UK
  • Sotiria Tsochataridou | Loughborough University | UK
  • Mariana Guilger | University of Sorocaba | Brazil
  • Suha M Dadou | University of Greenwich | UK
  • Meena Afzali | University of Greenwich | UK
  • Smirna Farias | University of Greenwich | UK
  • Amjad Alshawi | Bangor University | UK
  • Natalia Bilesky-José | University of Sorocaba | Brazil
  • Fahad Naif A Almutairi | Bangor University | UK

The event enlightened various areas of Pharmaceutics and plenary lectures from the speakers of various universities and organizations like

  • The London BioScience Innovation Centre | UK
  • University of Greenwich| UK
  • UCL School of Pharmacy |UK
  • University of Sorocaba | Brazil
  • Bangor University | UK
  • University of Guyana | Guyana
  • Loughborough University | UK
  • University of Strathclyde | UK
  • European Synchrotron Radiation Facility | France
  • University of Electronic Science and Technology of China| China
  • Haptic Systems | Poland


We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support, and assistance towards the success of Pharmaceutics 2018.

With the grand success of Pharmaceutics 2018, AAC is proud to announce the "2nd International Conference & Exhibition on Pharmaceutics and Novel Drug Delivery Systems” to be held during February 18-February 20, 2019 in Paris, France

For more information please visit: http://pharmaceutics.alliedacademies.com/

Organizing Committee
OCM Member
Heyam Saad Ali
Dubai Pharmacy College
Dubai, United Arab Emirates
OCM Member
Luisa Maria Arvide Cambra
University of Almería
Valencia, Spain
OCM Member
Alireza Heidari
Researcher, Department of Chemistry
California South University
Los Angeles, USA
OCM Member
Swarnlata Saraf
University Institute of Pharmacy
Raipur, India
OCM Member
Asif Mahmood
Clinical Research and Development
Pfizer
New York, USA
OCM Member
Mohamed Eddouks
Moulay Ismail University
Errachidia, Morocco
OCM Member
Xiang-chun Shen
Guizhou Medical University
Beijing, China
OCM Member
Zimei Wu
University of Auckland
Auckland, New Zealand

To Collaborate Scientific Professionals around the World

Conference Date February 18-20, 2019
Speaker Oppurtunity
Poster Oppurtunity Available
e-Poster Oppurtunity Available
Sponsorship Opportunities Click here for Sponsorship Opportunities
Venue
&
Hospitality

Holiday Inn Paris – Marne La Vallée

2 boulevard du Levant, 93160 Noisy-le-grand
France

Join The Discussion

Contact Desk

Sponsors/Exhibiting/Advertising

Madeline Leslie

sponsoraac@alliedacademies.com

+44 20 3769 1755

Testimonials

Special Issues
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by

Allied Academies Global Conference Directory

Mail us at

Program Enquiry
pharmaceutics@pharmaceuticsconferences.com
Sponsors/Exhibiting/Advertising
sponsoraac@alliedacademies.com
General Queries
pharmaceutics@alliedconferences.org
More details about sponsorship:sponsors@alliedacademies.com

Terms and Conditions

Responsibility

Delegates are personally responsible for their belongings at the venue. The Organizers will not be held responsible for any stolen or missing items belonging to Delegates, Speakers or Attendees; due to any reason whatsoever.

Insurance

Registration fees do not include insurance of any kind.

Transportation

Please note that any (or) all transportation and parking is the responsibility of the registrant.

Press/Media

Press permission must be obtained from Allied Academies Organizing Committee prior to the event. The press will not quote speakers or delegates unless they have obtained their approval in writing. The Allied academies are a non-profit organization. This conference is not associated with any commercial meeting company.

Requesting an Invitation Letter

For security purposes, letter of invitation will be sent only to those individuals who had registered for the conference. Once your registration is complete, please contact cardiacsurgery@surgerycongress.com to request a personalized letter of invitation.

Regarding refunds, all bank charges will be for the registrant's account.

Cancellation, Postponement and Transfer of Registration

All cancellations or modifications of registration must be made in writing to Program Manager (cardiacsurgery@alliedconference.net or finance@alliedacademies.com).

Cancellation Policy

If Allied academies cancel this event for any reason, you will receive a credit for 100% of the registration fee paid. You may use this credit for another Allied Academies Conferences (AAC) event which must occur within one year from the date of cancellation.

Postponement

If Allied academies postpone an event for any reason and you are unable or unwilling to attend on rescheduled dates, you will receive a credit for 100% of the registration fee paid. You may use this credit for another Allied Academies Conferences event which must occur within one year from the date of postponement.

Transfer of registration

All fully paid registrations are transferable to other persons from the same organization if registered person is unable to attend the event. Transfers must be made by the registered person in writing to Program ManagerDetails must be included with the full name of replacement person, their title, contact phone number and email address. All other registration details will be assigned to the new person unless otherwise specified.

Registration can be transferred to one conference to another conference of Allied academies if the person is unable to attend one of conferences.

However, Registration cannot be transferred if it is intimated within 14 days of the respective conference.

The transferred registrations will not be eligible for Refund.

Visa Information

Keeping in view of increased security measures, we would like to request all the participants to apply for Visa as soon as possible.

Allied Academies will not directly contact embassies and consulates on behalf of visa applicants. All delegates or invitees should apply for Business Visa only.

Important note for failed visa applications: Visa issues cannot come under the consideration of cancellation policy of Allied Academies, including the inability to obtain a visa.

Refund Policy:

If the registrant is unable to attend, and is not in a position to transfer his/her participation to another person or event, then the following refund arrangements apply:

Keeping in view of advance payments towards Venue, Printing, Shipping, Hotels and other overheads, we had to keep Refund Policy is as following slabs-

  • Before 60 days of the conference: Eligible for Full Refund less $100 service Fee
  • Within 60-30 days of Conference: Eligible for 50% of payment Refund
  • Within 30 days of Conference: Not eligible for Refund
  • E-Poster Payments will not be refunded.

Accommodation Cancellation Policy:

Accommodation Providers (Hotels) have their own cancellation policies, and they generally apply when cancellations are made less than 30 days prior to arrival. Please contact us as soon as possible, if you wish to cancel or amend your accommodation. Allied Academies will advise the cancellation policy of your accommodation provider, prior to cancelling or amending your booking, to ensure you are fully aware of any non-refundable deposits

Highlights from last year's Convention

Authorization Policy

Copyright © 2018-2019 Allied Academies, All Rights Reserved.